C
BPMC

Covestor’s Blueprint Medicines BPMC Stock Holding History

Covestor’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,365
Closed -$175K – 2302
2025
Q2 		$175K Buy
1,365
+237
+21% +$24.6K 0.1% 243
2025
Q1 		$100K Buy
1,128
+155
+16% +$15.1K 0.07% 489
2024
Q4 		$85K Buy
973
+375
+63% +$34.3K 0.05% 613
2024
Q3 		$55K Buy
598
+403
+207% +$40K 0.03% 837
2024
Q2 		$21K Sell
195
-99
-34% -$9.91K 0.01% 1176
2024
Q1 		$28K Buy
294
+291
+9,700% +$25K 0.02% 1085
2023
Q4 		$0 Sell
3
-1
-25% -$65 ﹤0.01% 2159
2023
Q3 		$0 Hold
4
– – ﹤0.01% 2133
2023
Q2 		$0 Sell
4
-1
-20% -$54 ﹤0.01% 2149
2023
Q1 		$0 Hold
5
– – ﹤0.01% 2039
2022
Q4 		$0 Hold
5
– – ﹤0.01% 2082
2022
Q3 		$0 Sell
5
-1
-17% -$64 ﹤0.01% 2012
2022
Q2 		$0 Sell
6
-123
-95% -$7.21K ﹤0.01% 1928
2022
Q1 		$8K Sell
129
-301
-70% -$21.6K 0.01% 1378
2021
Q4 		$46K Buy
+430
New +$45K 0.06% 584

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Covestor's BPMC Position: Q3 2025 in Review

Covestor sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 1,365 shares — an estimated $175K sold.

Covestor first reported a position in BPMC in Q4 2021 and held it in 15 quarters. The position peaked at $175K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Covestor reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Covestor sold 1,365 Blueprint Medicines shares in Q3 2025, an estimated $175K.
  • Covestor first reported a position in Blueprint Medicines in Q4 2021 and held it in 15 quarters.
  • Covestor's Blueprint Medicines position peaked at $175K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Covestor's 13F filing for Q3 2025, filed 30 Oct 2025.